When Lactobacillus kefiri DH5 treatment was given to HFD-fed mice, hepatic steatosis was significantly higher in the control group, while PPARα expression was significantly upregulated in the adipose tissue of the Lactobacillus-treated group [194]. Here, PPARA is linked to fatty liver disease.